Too much, too soon?: Commercial provision of noninvasive prenatal screening for subchromosomal abnormalities and beyond-Reference-Cited by-同舟云学术

Too much, too soon?: Commercial provision of noninvasive prenatal screening for subchromosomal abnormalities and beyond

Published:2015-12 Issue:12 Volume:17 Page:958-961
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Allyse Megan,Chandrasekharan Subhashini

Publisher

Elsevier BV

Subject

Genetics (clinical)

Link

http://www.nature.com/articles/gim201523.pdf

Reference36 articles.

1. Karow J. NIPS continues to take off in 2013 as indications, insurance coverage grow. GenomeWeb 2 January 2014.

2. United Healthcare. Noninvasive prenatal diagnosis of fetal aneuploidy using cell-free fetal nucleic acids in maternal blood. Policy no. 2014T0560E. https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Noninvasive_Prenatal_Diagnosis_of_Fetal_Aneuploidy.pdf. Accessed 1 April 2014.

3. Flessel M, Goldman S. California prenatal screening program to include noninvasive testing. ACOG, September 2013. http://www.acog.org/About-ACOG/ACOG-Departments/District-Newsletters/District-IX/September-2013/California-Prenatal-Screening-Program.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Invasive Prenatal Diagnostics: A Cornerstone of Perinatal Management;Applied Sciences;2024-08-07

2. Liability, risks, and recommendations for ultrasound use in the diagnosis of obstetrics diseases;Heliyon;2023-11

3. Women, Children, Families and the Translation of Genomics in Reproductive Medicine;The International Library of Bioethics;2021-11-25

4. Performance of a universal prenatal screening program incorporating cell-free fetal DNA analysis in Ontario, Canada;Canadian Medical Association Journal;2021-08-02

5. Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants;Genetics in Medicine;2021-07